Hence, we conducted a series of functional and mechanistic studies, which indicated a critical role of ALKBH5 in MM tumorigenesis as an m6A demethylase, thereby suggesting that ALKBH5 is a promising therapeutic target in MM. The gene discussed is ALKBH5; the disease is Miyoshi myopathy.